Wall Street Experts
ver. ZuMIgo(08/25)
Krystal Biotech, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 242
EBIT TTM (mln): 57
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
Rok finansowy |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
51 |
291 |
Przychód Δ r/r |
0.0% |
0.0% |
inf% |
-100.0% |
0.0% |
0.0% |
0.0% |
inf% |
473.0% |
Marża brutto |
0.0% |
0.0% |
100.0% |
-inf% |
-inf% |
-inf% |
-inf% |
84.0% |
93.1% |
EBIT (mln) |
-1 |
-5 |
-12 |
-22 |
-33 |
-68 |
-145 |
-97 |
66 |
EBIT Δ r/r |
0.0% |
317.5% |
149.7% |
85.3% |
49.4% |
106.9% |
112.7% |
-33.0% |
-167.6% |
EBIT (%) |
0.0% |
0.0% |
-1160.3% |
0.0% |
0.0% |
0.0% |
0.0% |
-191.8% |
22.6% |
Koszty finansowe (mln) |
0 |
3 |
1 |
0 |
0 |
1 |
5 |
0 |
0 |
EBITDA (mln) |
-1 |
-5 |
-12 |
-21 |
-31 |
-65 |
-111 |
-92 |
110 |
EBITDA(%) |
0.0% |
0.0% |
-1146.5% |
0.0% |
0.0% |
0.0% |
0.0% |
-181.9% |
37.8% |
Podatek (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
6 |
Zysk Netto (mln) |
-1 |
-8 |
-11 |
-19 |
-32 |
-70 |
-140 |
11 |
89 |
Zysk netto Δ r/r |
0.0% |
588.7% |
37.5% |
75.3% |
68.5% |
116.3% |
101.2% |
-107.8% |
715.6% |
Zysk netto (%) |
0.0% |
0.0% |
-1060.3% |
0.0% |
0.0% |
0.0% |
0.0% |
21.6% |
30.7% |
EPS |
-0.27 |
-1.48 |
-0.97 |
-1.2 |
-1.71 |
-3.13 |
-5.49 |
0.4 |
3.12 |
EPS (rozwodnione) |
-0.27 |
-1.48 |
-0.97 |
-1.2 |
-1.71 |
-3.13 |
-5.49 |
0.39 |
3.0 |
Ilośc akcji (mln) |
4 |
5 |
11 |
16 |
19 |
22 |
25 |
27 |
29 |
Ważona ilośc akcji (mln) |
4 |
5 |
11 |
16 |
19 |
22 |
25 |
28 |
30 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |